Despite multiple antihypertensive therapies, blood pressure (BP) control remains suboptimal in many individuals with persistent cardiovascular risk
GLP-1 medications should be prescribed and managed according to applicable clinical guidelines and regulations
This side effect is generally transient but should be monitored if: You experience palpitations Theres a noticeable, sustained increase over time Its advisable to have regular cardiac assessments while on GLP-1 medication, especially if you have underlying heart conditions
However, this depends on whether the industry can successfully capture GLP-1-related premiums to maintain economic viability
A pain redness or discoloration itching Injection site pain was the most frequent reaction reported overall and the most commonly reported within 60 minutes of the injection
Editor's note: This text-based course is a transcript of the webinar, GLP-1s and More: Pharmacology for Diabetes Mellitus and Other Endocrine Conditions, presented by Melissa Bednarek, PT, DPT, PhD, CCS